关联临床COVID-19生物标志物的当前情景,用于开发监控平台
Thangavel Lakshmipriya1, Subash C B Gopinath1,2,3,4,5, Yeng Chen6
1Center for Global Health Research, Saveetha Medical College & Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Thandalam, Chennai, 602105, Tamil Nadu, India.
Current medicinal chemistry
|January 14, 2025
概括
开发敏感且负担得起的COVID-19诊断系统对于早期检测至关重要. 基于纳米材料的生物传感器为准确的冠状病毒检测提供了有希望的新途径,克服了当前测试的局限性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 传染病诊断 传染病诊断 传染病诊断
背景情况:
- 由新型冠状病毒引起的COVID-19大流行,带来了独特的全球健康挑战.
- 现有的诊断方法,如实时聚合酶连锁反应 (RTPCR) 和抗体测试都有局限性,包括时间延迟和潜在的错误阳性.
- 迫切需要快速,灵敏和具有成本效益的COVID-19检测方法.
研究的目的:
- 审查COVID-19诊断系统的进展,重点关注基于纳米材料的传感器件.
- 探索潜在的冠状病毒生物标志物及其在生物传感器中用于早期检测的应用.
- 为开发新型诊断工具提供分析视角.
主要方法:
- 关于COVID-19诊断和纳米材料应用的科学文献的审查.
- 分析临床标记物及其整合到生物传感器平台.
- 探索用于早期检测冠状病毒的传感器件.
主要成果:
- 纳米材料为开发高度敏感和负担得起的COVID-19诊断系统提供了巨大的潜力.
- 早期检测策略正在通过新型传感器来推进.
- 这项工作提高了对生物传感器潜在生物标志物和分析方法的理解.
结论:
- 基于纳米材料的生物传感器代表了准确和快速的COVID-19诊断的前沿.
- 对生物标志物和传感器技术的持续研究对于对抗这场流行病至关重要.
- 开发具有成本效益和敏感的诊断工具对于全球卫生安全至关重要.
相关概念视频
01:26Principles of Disease Surveillance
853
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
853
01:23Investigation of Disease Outbreaks
74
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
74